SIRT1 and diabetes mellitus: The occurrence of diabetes can lead to a decrease in SIRT1 activity and its expression, and then the enhanced acetylation of FOXO1 will lead to a significant increase in blood glucose in vivo after FOXO1 activation, which may ultimately aggravate insulin resistance [44].